We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-29.17%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$122M
AUM Growth
-$127M
Cap. Flow
-$58.3M
Cap. Flow %
-47.69%
Top 10 Hldgs %
25.43%
Holding
188
New
64
Increased
19
Reduced
68
Closed
36

Top Buys

Rank Stock Value
1
RMR icon
The RMR Group
RMR
+$4.54M
2
IDCC icon
InterDigital
IDCC
+$4.48M
3
LRN icon
Stride
LRN
+$4.07M
4
MSTR icon
Strategy Inc
MSTR
+$2.79M
5
VVV icon
Valvoline
VVV
+$2.6M

Sector Composition

Rank Sector Weight
1 Technology 22.23%
2 Consumer Discretionary 15.57%
3 Industrials 12.32%
4 Healthcare 9.67%
5 Communication Services 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAL icon
51
Caleres
CAL
$486M
$891K 0.73%
171,314
+56,609
+49% +$813K
CLS icon
52
Celestica
CLS
$39.7B
$877K 0.72%
250,425
-240,690
-49% -$1.66M
FLEX icon
53
Flex
FLEX
$44.2B
$873K 0.71%
138,336
-285,954
-67% -$2.47M
VYX icon
54
NCR Voyix
VYX
$1.09B
$784K 0.64%
+72,178
New +$1.24M
GAP
55
The Gap Inc
GAP
$7.74B
$768K 0.63%
109,063
-44,465
-29% -$660K
WW
56
DELISTED
WW International
WW
$738K 0.6%
+43,594
New +$1.36M
HWCC
57
DELISTED
Houston Wire & Cable Company
HWCC
$738K 0.6%
336,566
-75,105
-18% -$258K
OI icon
58
O-I Glass
OI
$1.08B
$714K 0.58%
+100,475
New +$1.1M
PLPC icon
59
Preformed Line Products
PLPC
$2.26B
$696K 0.57%
13,956
+90
+0.6% +$4.76K
MIK
60
DELISTED
Michaels Stores, Inc
MIK
$695K 0.57%
428,573
+13,073
+3% +$61.9K
KGC icon
61
Kinross Gold
KGC
$32.5B
$683K 0.56%
+171,562
New +$830K
DFIN icon
62
Donnelley Financial Solutions
DFIN
$1.17B
$676K 0.55%
128,204
+29,178
+29% +$247K
IRIX icon
63
IRIDEX
IRIX
$14.7M
$660K 0.54%
410,284
+461
+0.1% +$1.19K
MAGN
64
Magnera Corp
MAGN
$466M
$605K 0.49%
+3,809
New +$750K
AVTA
65
DELISTED
Avantax, Inc. Common Stock
AVTA
$579K 0.47%
+48,080
New +$927K
LAZ icon
66
Lazard
LAZ
$4.16B
$555K 0.45%
+23,557
New +$872K
PRGS icon
67
Progress Software
PRGS
$1.78B
$526K 0.43%
+16,455
New +$663K
IP icon
68
International Paper
IP
$21.9B
$523K 0.43%
17,734
-6,697
-27% -$249K
USAP
69
DELISTED
Universal Stainless & Alloy
USAP
$521K 0.43%
67,615
-109,150
-62% -$1.28M
LAMR icon
70
Lamar Advertising Co
LAMR
$15.7B
$512K 0.42%
+9,992
New +$805K
SPY icon
71
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$512K 0.42%
118
-540
-82% -$165K
UHS icon
72
Universal Health Services
UHS
$10.2B
$510K 0.42%
+5,148
New +$652K
HSII
73
DELISTED
Heidrick & Struggles
HSII
$495K 0.4%
+22,023
New +$586K
WDR
74
DELISTED
Waddell & Reed Financial, Inc.
WDR
$483K 0.39%
+42,479
New +$633K
UFI icon
75
UNIFI
UFI
$129M
$474K 0.39%
+41,017
New +$842K

Similar funds

Invenomic Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Invenomic Capital Management held 188 positions worth $122M, down 51% from $249M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management withdrew a net $58.3M in Q1 2020, closing 36 positions and reducing 68 holdings. Its most notable exit was JetBlue, an estimated $6.96M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Invenomic Capital Management opened a new position in The RMR Group worth $3.16M.

  • Invenomic Capital Management's largest Q1 2020 buy was The RMR Group: 117,245 shares worth $3.16M.
  • Invenomic Capital Management added most to UGI in Q1 2020, an estimated $1.26M increase.
  • Invenomic Capital Management's biggest Q1 2020 reduction was Bausch Health, cutting an estimated $4.16M.
  • Invenomic Capital Management fully exited JetBlue in Q1 2020, selling an estimated $6.96M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $122M portfolio in Q1 2020.
  • Invenomic Capital Management opened 64 new positions and closed 36 in Q1 2020.
  • Invenomic Capital Management's portfolio value fell 51% quarter-over-quarter to $122M.

Based on Invenomic Capital Management's 13F filing for Q1 2020, filed 13 May 2020.